Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Irish developer of malaria vaccine wins European Inventor Award

Дата публикации: 03-07-2026 08:10:09

Adrian Hill’s highly effective vaccine exceeded the World Health Organization’s protection targets of 75pc to 80pc in clinical trials.
Read more: Irish developer of malaria vaccine wins European Inventor Award


Основное содержимое страницы с новостью.

Adrian Hill. Image: Tom Maurer Photography

Adrian Hill’s highly effective vaccine exceeded the World Health Organization’s protection targets of 75pc to 80pc in clinical trials.

Ireland’s Adrian Hill has received the European Patent Office’s European Inventor Award 2026 in the research category for his work developing the R21/Matrix-M malaria vaccine.

The highly effective vaccine achieved roughly 80pc protection in clinical trials, exceeding even World Health Organization (WHO) targets of 75pc. 

Designed for large-scale deployment in lower-income countries, the awarding body noted, the vaccine created by Hill and his team presents more of the malaria-specific protein regions needed to trigger a strong immune response, which offers significantly more protection against the disease than traditional vaccines. 

It costs less than €3 to make per dose and can remain stable for up to two years under standard refrigeration conditions, helping make vaccination programmes more accessible in regions where malaria remains endemic, according to the European Patent Office. 

Commenting on the win, Hill said, “I am delighted to accept this prestigious award on behalf of the many hundreds of people who have contributed to the discovery, development and licensure of our malaria vaccine over the past 12 years.”

Hill’s commitment to malaria research began in Gambia in 1988 when he witnessed the impact the illness can have, particularly on young children. According to the WHO, in 2024 there were 282m cases of malaria causing roughly 610,000 deaths globally. Three-quarters of those reported deaths were in Africa-based children under five. 

The project brought together partners including the University of Oxford, the Serum Institute of India, Novavax, and leading African research centres in Burkina Faso, Kenya, Mali and Tanzania. 

The awards show was held in Berlin; other inventors competing with Hill included Portuguese research finalist Paula Videira and her team, who were nominated for a high-precision antibody that distinguishes cancer cells from healthy tissue.

Finnish physicist Mikko Möttönen was considered for his work developing an ultrasensitive cryogenic microwave sensor that aims to improve quantum computing hardware.

Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Ireland bags four ERC grants to further medical research08.7330-06-2026
2Ireland’s greenhouse gas emissions have fallen by 2pc, finds EPA07.2208-07-2026
3Rinn centre and ArrayPatch to partner on skin cancer treatment07.3928-07-2026
4EU countries ahead of targets on public EV charging capacity07.5120-07-2026
5EEB urges Ireland to ensure simple climate rules deliver results07.1421-07-2026
6Scientists set off on RV Celtic Explorer to track ocean changes09.124-07-2026
7US firm launches vision-restoring implant with EU approval013.9622-07-2026
8Team Ireland makes it count at International Maths Olympiad011.823-07-2026
9Gates Medical Research Institute, Serum Institute ink agreement to manufacture novel TB vaccine0516-07-2026
10Reuters: вакцину от коронавируса компании Moderna будут производить во Франции0025-11-2020

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8. Источник: www.siliconrepublic.com.